
Hormone Insight is a health technology company offering a hyper-personalized, science-backed, and realistic care plan for women's hormonal health issues such as PCOS, Endometriosis, and hormonal acne. The platform uses AI and ML Ops combined with human-centered product innovation to create holistic care plans that include nutrition, workout, and stress management tailored to individual blood reports, lifestyle, and over 25 factors. The company differentiates itself by integrating expert knowledge from clinical nutritionists, gynecologists, and alternative therapy coaches to provide natural, personalized care that fits busy lifestyles. It targets women struggling with hormonal imbalances and aims to bring hormonal health to the forefront with easy-to-follow, personalized plans. The company is in growth mode with a waitlist and early access signups, emphasizing user research and expert advisory support.

Hormone Insight is a health technology company offering a hyper-personalized, science-backed, and realistic care plan for women's hormonal health issues such as PCOS, Endometriosis, and hormonal acne. The platform uses AI and ML Ops combined with human-centered product innovation to create holistic care plans that include nutrition, workout, and stress management tailored to individual blood reports, lifestyle, and over 25 factors. The company differentiates itself by integrating expert knowledge from clinical nutritionists, gynecologists, and alternative therapy coaches to provide natural, personalized care that fits busy lifestyles. It targets women struggling with hormonal imbalances and aims to bring hormonal health to the forefront with easy-to-follow, personalized plans. The company is in growth mode with a waitlist and early access signups, emphasizing user research and expert advisory support.
Sector: Women's hormonal health, healthtech
Product: AI-powered personalized hormonal health app (brand: Auvra) offering root-cause analysis and tailored care plans
Founded: 2024 (San Francisco)
Team size: 1–10 employees
Funding: Pre-Seed (Feb 10, 2025) — SBXi listed as investor
Women's hormonal health and chronic symptom management
2024
Healthtech / Wellness
“SBXi participated in the disclosed Pre-Seed round”